Birinyi Associates’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
Sell
-3,200
Closed -$203K 80
2015
Q3
$203K Buy
+3,200
New +$209K 0.09% 86
2015
Q2
Sell
-3,000
Closed -$208K 85
2015
Q1
$208K Sell
3,000
-1,400
-32% -$96.8K 0.14% 85
2014
Q4
$304K Sell
4,400
-200
-4% -$13.5K 0.14% 75
2014
Q3
$300K Sell
4,600
-200
-4% -$13.2K 0.14% 76
2014
Q2
$327K Sell
4,800
-400
-8% -$26.8K 0.15% 73
2014
Q1
$337K Sell
5,200
-670
-11% -$42.2K 0.17% 63
2013
Q4
$383K Buy
5,870
+70
+1% +$4.48K 0.2% 57
2013
Q3
$344K Sell
5,800
-1,250
-18% -$74.1K 0.19% 54
2013
Q2
$404K Buy
+7,050
New +$418K 0.24% 53

Other funds holding CL

Birinyi Associates's CL Position: Q4 2015 in Review

Birinyi Associates sold out of Colgate-Palmolive (CL) in Q4 2015, closing a stake of 3,200 shares — an estimated $203K sold.

Birinyi Associates first reported a position in CL in Q2 2013 and held it in 9 quarters. The position peaked at $404K in Q2 2013. 1,254 funds tracked by Wall St. Rank hold CL as of Q4 2015.

  • Birinyi Associates reported no remaining Colgate-Palmolive position as of Q4 2015 after selling out during the quarter.
  • Birinyi Associates sold 3,200 Colgate-Palmolive shares in Q4 2015, an estimated $203K.
  • Birinyi Associates first reported a position in Colgate-Palmolive in Q2 2013 and held it in 9 quarters.
  • Birinyi Associates's Colgate-Palmolive position peaked at $404K in Q2 2013.
  • 1,254 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q4 2015.

Based on Birinyi Associates's 13F filing for Q4 2015, filed 10 Feb 2016.